title: H1N1 influenza outcome in rheumatic patients under biological therapy.
authors.forename: Vasiliki-Kalliopi
authors.initials: VK
authors.lastname: Bournia
authors.forename: Charalampos
authors.initials: C
authors.lastname: Sfontouris
authors.forename: Maria
authors.initials: M
authors.lastname: Konsta
authors.forename: Alexios
authors.initials: A
authors.lastname: Iliopoulos
mesh_terms: D000328:Adult; D000998:Antiviral Agents / Q000627:therapeutic use; D001688:Biological Products / Q000009:adverse effects / Q000627:therapeutic use*; D005260:Female; D006115:Greece; D006801:Humans; D053118:Influenza A Virus, H1N1 Subtype / Q000472:pathogenicity*; D007251:Influenza, Human / Q000175:diagnosis / Q000188:drug therapy / Q000276:immunology / Q000821:virology*; D008297:Male; D008875:Middle Aged; D012216:Rheumatic Diseases / Q000188:drug therapy* / Q000276:immunology; D018570:Risk Assessment; D012307:Risk Factors; D013997:Time Factors; D016896:Treatment Outcome
chemical_list: D000998:Antiviral Agents; D001688:Biological Products